Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States
By
- AMS
posted
Jan 28, 2021 10:26 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Hyperhidrosis and the risk of being treated for skin infections
- AMS
Added Jul 05, 2021
Blog Entry
On-demand webinar: Scar Management - Roundtable Discussion
- AMS
Added Jan 12, 2022
Blog Entry
SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
- AMS
Added May 04, 2020
Blog Entry
Hugel Receives FDA Approval in the United States of Letybo (letibotulinumtoxinA-wlbg) for Injection for the Treatment of Glabellar Lines
The Aesthetic GUIDE
Added Mar 04, 2024
Blog Entry
Doctors Warn Against Do-It-Yourself Injections Trending During Pandemic
- AMS
Added Jun 16, 2021
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic